Wang Xiao-Ling, Lin Guo-Hua, Xu Nuo, Zeng Jing-Chun, Xu Dang-Han, Wang Shu-Xin
First Affiliated Hospital of Guangzhou University of CM, Guangzhou 510405, Guangdong Province, China.
Affiliated Hospital of Jining Medical University.
Zhongguo Zhen Jiu. 2020 Feb 12;40(2):193-6. doi: 10.13703/j.0255-2930.20190316-k00034.
To objectively evaluate the safety of acupoint catgut embedding therapy.
A total of 331 patients who received acupoint catgut embedding therapy were enrolled and summarized through the inpatient medical record system, follow-up record and adverse reaction report card. The statistical analysis was performed from the aspects of patients' gender, age, marital status, history of allergy, history of diabetes and the time, symptoms, duration and prognosis of adverse reactions, etc.
Among 331 patients who received acupoint catgut embedding therapy, 70 patients had adverse reactions, which were divided into 9 types, including post-treatment discomfort, local hematoma or subcutaneous hemorrhage, local swelling, local induration, severe pain, thread-body rejection, local pruritus, post-treatment body temperature rising, local redness, swelling, fever and pain. The incidence rate of adverse events was 21.15%, and the incidence of serious adverse events was 0. Among the patients with adverse reactions, 58 patients (82.86%) relieved without treatment, and 12 patients (17.14%) received after symptomatic treatment; all patients had no sequelae.
The acupoint catgut embedding therapy is relatively safe and the incidence of adverse reactions is low.
客观评价穴位埋线疗法的安全性。
通过住院病历系统、随访记录及不良反应报告单，纳入并总结331例接受穴位埋线疗法的患者。从患者的性别、年龄、婚姻状况、过敏史、糖尿病史以及不良反应的发生时间、症状、持续时间和预后等方面进行统计分析。
331例接受穴位埋线疗法的患者中，70例出现不良反应，分为9种类型，包括治疗后不适、局部血肿或皮下出血、局部肿胀、局部硬结、剧痛、线体排斥、局部瘙痒、治疗后体温升高、局部红、肿、热、痛。不良事件发生率为21.15%，严重不良事件发生率为0。出现不良反应的患者中，58例（82.86%）未经治疗缓解，12例（17.14%）经对症治疗后缓解；所有患者均无后遗症。
穴位埋线疗法相对安全，不良反应发生率低。
